To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Drug Delivery Market size was valued at USD 17.04 billion in 2021 and is poised to grow from USD 18.47 billion in 2022 to USD 35.21 billion by 2030, growing at a CAGR of 8.4% in the forecast period (2023-2030).

The drug delivery market is highly competitive and dynamic, characterised by the presence of numerous players operating across various segments and regions. This market encompasses a wide range of technologies and devices designed to deliver drugs efficiently and effectively to patients. The competitive landscape of the drug delivery market is shaped by factors such as technological advancements, product innovation, strategic collaborations, and regulatory compliance. 'Johnson & Johnson (US)', 'Pfizer Inc. (US)', 'Novartis International AG (Switzerland)', 'GlaxoSmithKline plc (United Kingdom)', 'Merck & Co., Inc. (US)', 'Sanofi (France)', 'AstraZeneca plc (United Kingdom)', 'Roche Holding AG (Switzerland)', 'Eli Lilly and Company (US)', 'Bayer AG (Germany)', 'Bristol-Myers Squibb Company (US)', 'AbbVie Inc. (US)', 'Amgen Inc. (US)', 'Novo Nordisk A/S (Denmark)', 'Gilead Sciences, Inc. (US)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Biogen Inc. (US)', 'Astellas Pharma Inc. (Japan)', 'Boehringer Ingelheim International GmbH (Germany)', 'Daiichi Sankyo Company, Limited (Japan)'

The drug delivery market is witnessing an increasing trend towards self-administration of medications and home healthcare. Patients are increasingly seeking convenience and independence in managing their medications. User-friendly and portable drug delivery devices such as autoinjectors, inhalers, and insulin pens have emerged to meet this demand. These devices empower patients to administer medications at home, reducing the need for frequent hospital visits and enhancing overall convenience and patient satisfaction.

Increasing focus on targeted drug delivery systems: Targeted drug delivery involves delivering medications directly to specific sites in the body, allowing for localised treatment and minimising systemic side effects. This trend is driven by the need for more precise and effective drug therapies, especially in complex diseases such as cancer, autoimmune disorders, and chronic conditions. Targeted drug delivery systems utilise various technologies such as nanoparticles, liposomes, micelles, and implantable devices to deliver drugs to specific tissues, organs, or cells. These systems offer advantages such as enhanced drug efficacy, reduced dosage requirements, improved patient compliance, and minimise off-target effects.

North America has historically held a significant share in the pacemaker market, attributed to its well-developed healthcare infrastructure, high healthcare expenditure, and a large patient pool. The region has a strong presence of key market players, advanced technological advancements, and a high adoption rate of pacemaker technologies. Additionally, favourable reimbursement policies and increased awareness about cardiovascular diseases contribute to the dominance of North America in the pacemaker market.

Feedback From Our Clients

Global Drug Delivery Market

Product ID: SQMIG35C2017

$5,300
BUY NOW